IP Library Granted Patent US 7,449,319
Granted Patent B2
US 7,449,319 · App. 11/329,498 · Granted Nov 11, 2008

EGVII endoglucanase and nucleic acids encoding the same

Assignee: Daniaco A/S, Genencor Division
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,449,319
App. No.
11/329,498
Granted
Nov 11, 2008
Kind
B2
Abstract

The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.

Claims (5)

1. A substantially purified EGVII polypeptide with the biological activity of an endoglucanase, comprising

(a) an amino acid sequence having at least 95% sequence identity to SEQ ID NO:2; or

(b) a biologically active fragment of the amino acid sequence of SEQ ID NO:2.

2. The substantially purified EGVII polypeptide of claim 1 (a) having at least 98% sequence identity to SEQ ID NO:2.

3. An isolated polypeptide comprising SEQ ID NO:2.

Assignments (1)
CONFIRMATORY LICENSE Recorded Mar 15, 2012
From: DANISCO US INC.
To: UNITED STATE DEPARTMENT OF ENERGY
Reel/Frame 027882/0846 →
Continuity (2)
Division 1002824400 · Dec 18, 2001
Related Publication 20060135388A1 · Jun 22, 2006